Eliminating routine but low-value preoperative tests for cataract surgery patients associated with cost savings
FINDINGSUCLA researchers found that eliminating routine but unnecessary procedures before people undergo cataract surgery has the potential to save costs and resources for hospitals serving lower-income patients.Forgoing routine chest x-rays, electrocardiograms and other preoperative procedures — which studies have found to have no clinical benefit prior to cataract surgery — was associated with a savings of $67,241 over three years at one of the medical centers analyzed in the study. The change was also associated with other benefits – for instance, one licensed vocational nurse had approximately 70 perc...
Source: UCLA Newsroom: Health Sciences - April 16, 2019 Category: Universities & Medical Training Source Type: news

BioSig raises $9m
BioSig Technologies (OTCQB: BSGM) has raised $8.6 million in a new round of equity financing, according to a recently posed SEC filing. The Santa Monica, Calif.-based company is developing the Pure EP system, which is designed for acquiring, digitizing, amplifying, filtering, measuring and calculating, displaying, recording and storing electrocardiographic and intracardiac signals for patients undergoing electrophysiology procedures. The device is intended to reduce noise and artifacts to produce high-fidelity cardiac signals, which the company claims could increase the diagnostic values of the signals. BioSig is...
Source: Mass Device - March 29, 2019 Category: Medical Devices Authors: Fink Densford Tags: Business/Financial News Wall Street Beat BioSig Technologies Source Type: news

Detecting Arrhythmias in Clinical Trials Using ECG Monitoring, New...
Clinical trials in cardiovascular medicine have grown in size, scope and complexity, requiring instruments for monitoring the heart to keep pace. Electrocardiographic (ECG) monitoring has evolved from...(PRWeb March 21, 2019)Read the full story at https://www.prweb.com/releases/detecting_arrhythmias_in_clinical_trials_using_ecg_monitoring_new_webinar_hosted_by_xtalks/prweb16185858.htm (Source: PRWeb: Medical Pharmaceuticals)
Source: PRWeb: Medical Pharmaceuticals - March 21, 2019 Category: Pharmaceuticals Source Type: news

National Mobile X-Ray buys MMDS
Mobile x-ray, ultrasound, and electrocardiogram technology provider National...Read more on AuntMinnie.com (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - March 19, 2019 Category: Radiology Source Type: news

ACC 2019 Roundup – ReCor touts six-month Paradise renal denervation study results
This study effectively shows that by giving health consumers the tools they need to better manage their health, we can empower them to live healthier lives,” senior study author and chief medical officer Dr. Bimal Shah said in a prepared statement. Read more  Neovasc presents Reducer data Neovasc (NSDQ:NVCN) said today that it released data on its Neovasc Reducer device during the American College of Cardiology’s 68th Annual Scientific Sessions in New Orleans. During the session, researchers explored the treatment of refractory angina in patients with no options, Vancouver-based Neovasc said, tou...
Source: Mass Device - March 19, 2019 Category: Medical Devices Authors: Fink Densford Tags: Cardiac Assist Devices Cardiovascular Clinical Trials Featured Patient Monitoring ReCor Medical Source Type: news

Electronic Order Set May Reduce Inappropriate ECG Monitoring
WEDNESDAY, March 6, 2019 -- Use of electronic order sets is a safe and effective way to enhance appropriate electrocardiographic (ECG) monitoring of hospitalized patients, according to a study published in the March issue of the American Journal of... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - March 6, 2019 Category: Pharmaceuticals Source Type: news

Is AI a Fad or a Sure-Fire Thing in Medtech?
The growing popularity of artificial intelligence in medtech was pretty obvious in 2018. The use of AI in creating new applications or enhancing existing ones was perhaps the hottest trend in the medical device industry last year. But that was 2018. What about this year and just what does the future hold for AI. One medtech executive/entrepreneur thinks that 2019 will be the year of validation for AI. Yann Fleureau, the co-founder and CEO of Cardiologs, a Paris-based company building deep learning algorithms for ECG analysis, spoke with MD+DI about one of the AI and its expected impact. “I think we will s...
Source: MDDI - March 4, 2019 Category: Medical Devices Authors: Omar Ford Tags: Digital Health Source Type: news

HEART Care Pathway Reduces Admission, Stress Testing in ACS
THURSDAY, Feb. 28, 2019 -- Implementing a history, electrocardiogram, age, risk factors, and troponin (HEART) care pathway can reduce use of hospital care and noninvasive stress testing among patients with suspected acute coronary syndrome (ACS),... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - February 28, 2019 Category: Pharmaceuticals Source Type: news

AliveCor Appoints Dr. Jacqueline Shreibati, Chief Medical Officer
MOUNTAIN VIEW, Calif., Feb. 26, 2019 -- (Healthcare Sales & Marketing Network) -- AliveCor, the leader in FDA-cleared personal electrocardiogram (ECG) technology, today announced Jacqueline Shreibati, MD, MS, FACC, as Chief Medical Officer of the company.... Devices, Cardiology, Personnel AliveCor, KardiaMobile, ECG (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - February 26, 2019 Category: Pharmaceuticals Source Type: news

Biotronik Has a New DES Added to its Repertoire
FDA has just signed off on Biotronik’s Orsiro drug-eluting stent (System). The Lake Oswego, OR-based company claims the stent is the first and ultrathin DES to outperform Abbott Laboratories’, Xience stent, which is known as the clinical standard. Biotronik said its first implants will occur this week and that it will be available in health systems in the early part of this year. The company has had CE mark for Orsiro since 2011. Perhaps the biggest selling point of the technology is the ultrathin strut design. “Thinner struts are different in that they potentially crea...
Source: MDDI - February 25, 2019 Category: Medical Devices Authors: Omar Ford Tags: Cardiovascular Business Source Type: news

What Is the Most Common Type of Cardiomyopathy?
Discussion Barth syndrome is characterized by a dilated cardiomyopathy, proximal skeletal muscle weakness, neutropenia and short stature that usually presents at birth or soon after. It is a rare X-linked recessive disease process caused by mutations in the TAZ gene. The TAZ gene codes for tafazzin which alters cardiolipin in mitochondria. Characteristic facies can be seen especially in infancy including a tall and broad forehead, prominent chin and full cheeks, larger ears, and deep-set eyes. Most patients present at birth or soon afterwards but some may not until later in life. Life expectancy is reduced with many childr...
Source: PediatricEducation.org - February 25, 2019 Category: Pediatrics Authors: pediatriceducationmin Tags: Uncategorized Source Type: news

Syncope Monitoring in ED: 2 Hours Okay for Low-Risk Patients Syncope Monitoring in ED: 2 Hours Okay for Low-Risk Patients
Patients with syncope who present to the emergency department and who are at low risk for serious arrhythmia can be discharged home after 2 hours of electrocardiogram monitoring, new data show.Medscape Medical News (Source: Medscape Cardiology Headlines)
Source: Medscape Cardiology Headlines - February 13, 2019 Category: Cardiology Tags: Emergency Medicine News Source Type: news

Underfunding drives practices to stop providing non-core services
Eight GP practices in Buckinghamshire have decided to discontinue the provision of underfunded non-core services.   Writing to Berkshire, Buckinghamshire& Oxfordshire (Bucks, Berks& Oxon) LMCs last December, the practices announced their decision to cease the provision of seven different services by August this year at the latest.  These include ear syringing, 24-hour blood pressure monitoring, spirometry for diagnosis, ECGs, ring pessary, PSA monitoring and MGUS monitoring. Hide related content:  Show related contentread more (Source: Management in Practice)
Source: Management in Practice - February 11, 2019 Category: Practice Management Authors: Angela Sharda Tags: *** Editor ' s Pick Latest News Source Type: news

FDA OKs ECG Feature on Verily Study Watch for Research FDA OKs ECG Feature on Verily Study Watch for Research
The Verily Study Watch records, stores, transfers, and displays single-channel electrocardiogram data as part of clinical research studies.FDA Approvals (Source: Medscape Neurology and Neurosurgery Headlines)
Source: Medscape Neurology and Neurosurgery Headlines - January 21, 2019 Category: Neurology Tags: Cardiology News Alert Source Type: news

FDA clears Verily ’ s Study Watch for on-demand ECG
Alphabet‘s (NSDQ:GOOGL) life sciences group, Verily, said today that it won 510(k) clearance from the FDA for its Study Watch for its on-demand electrocardiogram feature. In a blog post published today, the head of Verily’s cardiovascular health innovations unit, Dr. Michael McConnell, wrote that the Study Watch indication covers the recording, storage, transfer and display of single-channel ECG rhythms. “The ability to take an on-demand, single-lead ECG, can support both population-based research and an individual’s clinical care,” McConnell wrote. “Receiving this clearance showcas...
Source: Mass Device - January 18, 2019 Category: Medical Devices Authors: Brad Perriello Tags: Cardiovascular Featured Food & Drug Administration (FDA) Regulatory/Compliance Verily Source Type: news

Not Just Acid Reflux: The Need to Think Worst First
A previously healthy, well-appearing 42-year-old female living in a modern, high-rise apartment in downtown Los Angeles calls 9-1-1 at 5:30 am complaining of worsening of a burning, epigastric pain she had been experiencing for the last three days. She reports associated nausea and non-bloody, non-bilious vomiting, and that she couldn’t manage to get comfortable in bed until she finally decided to call for help at daybreak. During her 9-1-1 call, she reports “pain, like heartburn, that just woke me up again and I had to throw up, … and then I was sweating so much.” Using the Los Angeles Tiered Disp...
Source: JEMS Special Topics - January 13, 2019 Category: Emergency Medicine Authors: Stephen Sanko, MD, FACEP Tags: Exclusive Articles Cardiac & Resuscitation Source Type: news

Artificial Intelligence Can Use Routine ECGs to ID Heart Disease
FRIDAY, Jan. 11, 2019 -- Artificial intelligence (AI) can identify asymptomatic left ventricular dysfunction (ALVD) using results from a routine electrocardiogram (ECG), according to a research letter published online Jan. 7 in Nature... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - January 11, 2019 Category: Pharmaceuticals Source Type: news

iRhythm Finds Its Groove at the Intersection of Cardiology and AI
iRhythm Technologies has the distinct feature of being at the intersection of some of the hottest markets in medtech – cardiology, wearables, and artificial intelligence. The San Francisco-based company has developed, the Zio Patch XT, a wearable technology to monitor heart rate activity for up to 14 days and is set to present at the 37th Annual J.P. Morgan Healthcare Conference this week. Tim King, iRhythm’s president and CEO spoke to MD+DI ahead of the company’s presentation about the company's success and its goals going forward. “The tool of choice...
Source: MDDI - January 8, 2019 Category: Medical Devices Authors: Omar Ford Tags: Cardiovascular Digital Health Source Type: news

Mayo Clinic research uses artificial intelligence to develop inexpensive, widely available early detector of silent heart disease
ROCHESTER, Minn. -- A Mayo Clinic study finds that applying artificial intelligence (AI) to a widely available, inexpensive test - the electrocardiogram (EKG) - results in a simple, affordable early indicator of asymptomatic left ventricular dysfunction, which is a precursor to heart failure. The research team found that the AI/EKG test accuracy compares favorably with [...] (Source: News from Mayo Clinic)
Source: News from Mayo Clinic - January 7, 2019 Category: Databases & Libraries Source Type: news

New Apple Watch OK'd for Arrhythmia Detection
(MedPage Today) -- Single-lead electrocardiogram built into latest version cleared by FDA (Source: MedPage Today Public Health)
Source: MedPage Today Public Health - December 28, 2018 Category: American Health Source Type: news

Could Your Apple Watch Spot Dangerous A-Fib?
The watch contains a simple electrocardiogram (ECG) that tracks your heart rhythm and can detect the presence of atrial fibrillation ("A-fib"), an irregular heartbeat that increases your risk for stroke and heart failure. (Source: WebMD Health)
Source: WebMD Health - December 27, 2018 Category: Consumer Health News Source Type: news

Could Your Apple Watch Spot Dangerous A-Fib?
THURSDAY, Dec. 27, 2018 -- That shiny new Apple Watch you got this holiday could potentially alert you to heart trouble you didn't know you had. The watch contains a simple electrocardiogram (ECG) that tracks your heart rhythm and can detect the... (Source: Drugs.com - Daily MedNews)
Source: Drugs.com - Daily MedNews - December 27, 2018 Category: General Medicine Source Type: news

Report: Apple hiring dozens of MDs, solidifies venture into healthcare
Apple (NSDQ:AAPL) has hired dozens of medical doctors for positions with various teams at the company, confirming its plans to move into the healthcare biz, according to a recent CNBC report. Many of the hires have been under the radar, according to the report, which estimates the company has more than 40 and up to 50 doctors on its roster. The move suggests that Apple may be looking to integrate more health technologies into its platforms, and that it could be looking to branch out into applications for people with specific serious medical conditions and not focus as much on general wellness, CNBC reports. The medica...
Source: Mass Device - December 13, 2018 Category: Medical Devices Authors: Fink Densford Tags: Business/Financial News Featured Research & Development Apple Source Type: news

EKG, Other Heart Health Features Come to Apple Watch
NEW YORK (AP) — Apple Watch is now fulfilling its promise to let people take EKGs of their heart and notify them of any irregular heartbeat. Apple announced the heart features in September, but didn't make them available until Thursday. The new features have been given clearance by the U.S. Food and Drug Administration and are for U.S. customers only. Related JEMS Article: The iBeat Is a ‘Smart’ Watch, But It Can’t ‘Save Your Life’ The watch can intermittently check the wearer's heart rhythm in the background and send a notification if it detects irregular heart rhythm. That can poi...
Source: JEMS Patient Care - December 7, 2018 Category: Emergency Medicine Authors: Associated Press Tags: Cardiac & Resuscitation News Source Type: news

EKG, Other Heart Health Features Come to Apple Watch
NEW YORK (AP) — Apple Watch is now fulfilling its promise to let people take EKGs of their heart and notify them of any irregular heartbeat. Apple announced the heart features in September, but didn't make them available until Thursday. The new features have been given clearance by the U.S. Food and Drug Administration and are for U.S. customers only. Related JEMS Article: The iBeat Is a ‘Smart’ Watch, But It Can’t ‘Save Your Life’ The watch can intermittently check the wearer's heart rhythm in the background and send a notification if it detects irregular heart rhythm. That can poi...
Source: JEMS: Journal of Emergency Medical Services News - December 7, 2018 Category: Emergency Medicine Authors: Associated Press Tags: Cardiac & Resuscitation News Source Type: news

Apple Watch rolling out electrocardiogram feature
According to Apple, this new test can detect atrial fibrillation, a potentially serious condition where the heart beats out of rhythm (Source: Health News: CBSNews.com)
Source: Health News: CBSNews.com - December 6, 2018 Category: Consumer Health News Source Type: news

Dr. Sanjay Gupta tests the Apple Watch's new heart monitor
Since the Apple Watch Series 4 was announced in September, one of its most anticipated functions has been the promise to perform a mobile electrocardiogram (ECG or EKG) whenever a consumer wants. The feature becomes available in the United States on Thursday via a software update. (Source: CNN.com - Health)
Source: CNN.com - Health - December 6, 2018 Category: Consumer Health News Source Type: news

Apple Watch rolling out electrocardiograms for heart health
Wearable technology is a more than $21 billion market and is on track to reach nearly $35 billion in the next four years. Smart watches are driving the trend. Apple is launching two new Apple Watch features Thursday for heart health. Norah O'Donnell met Apple COO Jeff Williams and vice president of health Dr. Sumbul Desai to learn how the Apple Watch is tracking atrial fibrillation, a disorder that affects at least 2.7 million Americans. Cardiologist Dr. Tara Narula also joins "CBS This Morning" to weigh in on the new features. (Source: Health News: CBSNews.com)
Source: Health News: CBSNews.com - December 6, 2018 Category: Consumer Health News Source Type: news

ECG Educational Standards for Prehospital Providers
The level of knowledge pertaining to electrocardiogram (ECG) interpretation among prehospital healthcare providers undoubtedly impacts patient outcomes. EMS personnel from EMRs to EMTs, AEMTs and paramedics play a critical role in the care of acutely ill and injured patients. First responders make critical decisions regarding initial assessment, intervention and transport. They must do so expeditiously. Such decisions have profound implications on quality and continuity of care. The importance of such actions becomes especially evident in regard to on-scene ECG interpretation. The prehospital providers' ECG interpretation ...
Source: JEMS Patient Care - November 28, 2018 Category: Emergency Medicine Authors: Jonathan Barney, BA, EMT, MS3 Tags: Training Exclusive Articles Cardiac & Resuscitation Source Type: news

ECG Educational Standards for Prehospital Providers
Conclusion As the role of evidence-based medicine becomes more prominent in the field of emergency medicine, a clear view of the current state of ECG education and platform from which to implement uniform standards becomes increasingly essential; especially as research expands into the prehospital setting. Further research into EMS education may identify both strengths and weaknesses in basic ECG interpretation appropriate for first responders. Implementing minimum ECG interpretation standards for EMS personnel nationwide is one potential option to ensure prehospital educational institutions stay responsive to current scie...
Source: JEMS Special Topics - November 28, 2018 Category: Emergency Medicine Authors: Jonathan Barney, BA, EMT, MS3 Tags: Training Exclusive Articles Cardiac & Resuscitation Source Type: news

BioSig inks Pure EP first-in-human study deal with Texas Cardiac Arrhythmia Institute
BioSig Technologies (OTCQB: BSGM) said today that it inked a deal with Austin’s Texas Cardiac Arrhythmia Institute at St. David’s Medical Center to launch first-in-human studies using its Pure EP system. The Santa Monica, Calif.-based company’s Pure EP system is designed for acquiring, digitizing, amplifying, filtering, measuring and calculating, displaying, recording and storing electrocardiographic and intracardiac signals for patients undergoing electrophysiology procedures. The device is intended to reduce noise and artifacts to produce high-fidelity cardiac signals, which the company claims...
Source: Mass Device - November 27, 2018 Category: Medical Devices Authors: Fink Densford Tags: Business/Financial News Cardiovascular Clinical Trials BioSig Technologies Source Type: news

AliveCor Heats up Mobile ECG Market with New Data
A research version of AliveCor’s mobile ECG technology could help rapid diagnosis and treatment of heart attacks, according to a study presented at the 2018 American Heart Association’s Scientific Sessions in Chicago. The ST LEUIS International Multicenter Study determined that the Mountain View, CA-based company’s smartphone technology can identify the condition with good correlation and high sensitivity compared to a standard-lead ECG. A total of 204 subjects (age = 60 years, males = 57%, STEMI activation = 45%) were enrolled from 5 international sites. For all interp...
Source: MDDI - November 12, 2018 Category: Medical Devices Authors: Omar Ford Tags: Business Cardiovascular Source Type: news

Apple Watch study enrolls 400k participants
An atrial fibrillation screening study using Apple‘s (NSDQ:AAPL) next-gen Apple Watch has enrolled 400,000 subjects, making it the largest study of its kind to date. Enrollment for the Apple Heart trial has been completed by Stanford University’s School of Medicine, and the study rationale and design has already been published in the American Heart Journal. “The advantage of the app that uses the optical sensor is that it can check for an irregular pulse multiple times throughout the day in the background, without needing the user to actively engage the application,” study principal investigator Mar...
Source: Mass Device - November 2, 2018 Category: Medical Devices Authors: Fink Densford Tags: Cardiovascular Clinical Trials Featured Patient Monitoring Apple Source Type: news

Researchers combine separate technologies to develop new digital stethoscope design
(Rochester Institute of Technology) Researchers developed a new digital stethoscope that combines precision sensors, electrocardiogram technology and machine learning applications into one piece of equipment to better detect heart ailments and problems that might occur with an implanted heart pump. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - October 26, 2018 Category: International Medicine & Public Health Source Type: news

Managing the Toxic Chemical Release that Occurs During a Crush Injury
Conclusion Remember, crush injuries are a different form of trauma that require a very different mindset and approach to patient care. Local physiologic deterioration can begin very quickly, but systemic effects aren’t seen until the external pressure on the extremity or body part is released. The presentation of crush injuries can also be very clandestine, as in automobile accidents, due to local or central sensory neurological interruption and damage. Therefore, it’s essential to insist upon earliest possible access to the patient to assess the possible/probable extent of any crush injury and prepare/monitor ...
Source: JEMS Special Topics - October 23, 2018 Category: Emergency Medicine Authors: Andrew Parrish, MD, EMT-P Tags: Trauma Exclusive Articles Source Type: news

Smartphone ECG Can Spot AF in Acute Stroke, Add to Holter Data Smartphone ECG Can Spot AF in Acute Stroke, Add to Holter Data
However, using a smartphone for electrocardiography in hospitalized stroke patients'is only one of several methods, and it's probably not going to be a gold standard,'but rather an add-on, says an expert.Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - October 19, 2018 Category: Consumer Health News Tags: Neurology & Neurosurgery News Source Type: news

High Risk for Readmission for Takotsubo Syndrome
TUESDAY, Oct. 16, 2018 -- Patients with Takotsubo syndrome (TTS), which is characterized by transient left ventricular dysfunction with symptoms and electrocardiogram changes mimicking acute myocardial infarction (AMI), have lower mortality during... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - October 16, 2018 Category: Pharmaceuticals Source Type: news

NYT Report: Apple Watch ‘ should not be considered a medical device ’
The new electrocardiogram-equipped Apple (NSDQ:AAPL) Watch should not be considered a medical device, according to a new report from the New York Times. The article, written by Indiana University School of Medicine pediatrics professor Aaron Carroll, calls into question the downsides of the newly released device and the potential for both false positives and false negatives. Carroll acknowledged the possible positives of the device, including the ability for physicians to monitor patients from a distance and diagnosing heart problems in individuals that would possibly go undetected, but said that “just because s...
Source: Mass Device - October 10, 2018 Category: Medical Devices Authors: Fink Densford Tags: Business/Financial News Diagnostics mHealth (Mobile Health) Apple Source Type: news

Airway, Breathing or Consequences: Use Your Tools and Trust the Technology
“An esophageal intubation is no sin, but there is great sin in not recognizing such a placement.” — Special Operations Combat Medical Skills Sustainment Course (U.S. Special Operations Command) How hard is it take to properly intubate the trachea? Actually, it’s far more difficult than most people think. Recent anesthesia research shows that at least 75 live adult intubations are needed to achieve a 90% initial competency.1 Yes, 75! Not the very limited live number that are experienced in many paramedic schools, and certainly not only practicing with manikins. And how hard is it to intubate the esop...
Source: JEMS Special Topics - October 2, 2018 Category: Emergency Medicine Authors: Scott DeBoer, RN, MSN, CEN, CPEN, CCRN, CFRN, EMT-P Tags: Airway & Respiratory Exclusive Articles Source Type: news

Could MRI imaging detect early signs of heart disease in lupus sufferers?
Lupus is an autoimmune disease that causes inflammation in the joints, skin and many other organs throughout the body. Modern treatments have improved the outlook for people with lupus, however there is currently no cure. It remains a variable and unpredictable condition and may even be life-threatening for people whose vital organs, like the heart, are affected. Careful monitoring of the condition is needed so that potentially serious complications can be recognised and treated promptly, and a team of researchers seems to have made a major leap forward in this area. The group from China's Shanghai Jiao Tong University...
Source: Arthritis Research UK - September 25, 2018 Category: Rheumatology Source Type: news

What Causes Hyperkalemia?
Discussion Potassium (K+) is an alkali metal (Group 1 of periodic table with Hydrogen, Lithium and Sodium) with an anatomic number of 19. Its chemical symbol K, comes from the medieval Latin, kalium which means potash (mainly potassium carbonate or potassium hydroxide), the substance it was first isolated from. Potassium is an important cation and it mainly resides in the intracellular fluid with only a small amount in the extracellular fluid. Potassium regulates cell volume, pH and enzyme functions. Hyperkalemia is defined as a potassium level> 5.5 mEq/L in children and> 6.0 mEq/L in newborns. Hyperkalemia incre...
Source: PediatricEducation.org - September 24, 2018 Category: Pediatrics Authors: pediatriceducationmin Tags: Uncategorized Source Type: news

BioSig to uplist to NASDAQ exchange
BioSig Technologies (OTCQB: BSGM) said this week it plans to uplist onto the Nasdaq Capital Market, beginning today. The Santa Monica, Calif.-based company said that the uplisting follows its receipt of FDA 510(k) clearance for its Pure EP electrophysiology system. BioSig said that the PureEP system is designed for acquiring, digitizing, amplifying, filtering, measuring and calculating, displaying, recording and storing electrocardiographic and intracardiac signals for patients undergoing electrophysiology procedures. “We are extremely pleased to be stepping onto the Nasdaq Capital Market at this pivotal po...
Source: Mass Device - September 21, 2018 Category: Medical Devices Authors: Fink Densford Tags: Business/Financial News Wall Street Beat BioSig Technologies Source Type: news

Responses To Innovation: Apple Watch Vs. The Specialists
The electrocardiogram obtained by Apple Watch provides a much more imperfect and rudimentary result than a hospital or a dedicated device would. But the measurements, although less rigorous, can be taken and analyzed continuously, at any time of the day. We are witnessing the future of Medicine. (Source: Forbes.com Healthcare News)
Source: Forbes.com Healthcare News - September 16, 2018 Category: Pharmaceuticals Authors: Enrique Dans, Contributor Tags: NASDAQ:AAPL Source Type: news

FDA hopes new disruptive wearables will lead to ‘ universal digital future in healthcare ’
The FDA is hopeful that devices like the new Apple (NSDQ:AAPL) Watch, which is designed to provide on-the-spot electrocardiogram tests and detect atrial fibrillation, will lead to a “reimagination of healthcare delivery,” according to a recent post from agency head Dr. Scott Gottlieb, but whether having that data will improve overall health has yet to be seen. In its unveiling of the new Apple Watch 4, the Cupertino, Calif.-based tech giant said it worked closely with the FDA to clear the device, which won de novo classification from the federal watchdog. Gottlieb confirmed that the agency “worked cl...
Source: Mass Device - September 14, 2018 Category: Medical Devices Authors: Fink Densford Tags: Diagnostics Food & Drug Administration (FDA) Regulatory/Compliance AliveCor Apple Source Type: news

PHOTOS: Apple reveals biggest, most expensive iPhone yet and new Watch with FDA approval
Apple Inc. (NASDAQ:AAPL) executives took to the stage at the company's Cupertino, California, headquarters on Wednesday to unveil a lineup of bigger, pricier iPhones and a revamped Apple Watch with new health and medical features and a first-of-its-kind approval from federal drug regulators. The company unveiled a new Apple Watch with an electrical heart rate sensor and new software to detect irregular heart rhythms. The device is the first "over the counter" electrocardiography (ECG) device that… (Source: bizjournals.com Health Care:Biotechnology headlines)
Source: bizjournals.com Health Care:Biotechnology headlines - September 13, 2018 Category: Biotechnology Authors: SVBJ staff Source Type: news

Apple debuts biggest, most expensive iPhone yet
Apple Inc. executives took to the stage at the company's Cupertino, California, headquarters Wednesday to unveil a lineup of bigger, pricier iPhones and a revamped Apple Watch with new health and medical features and a first-of-its-kind approval from federal drug regulators. The company unveiled a new Apple Watch with an electrical heart rate sensor and new software to detect irregular heart rhythms. The device is the first "over the counter" electrocardiography (ECG) device that has received… (Source: bizjournals.com Health Care News Headlines)
Source: bizjournals.com Health Care News Headlines - September 13, 2018 Category: Health Management Authors: By Silicon Valley Business Journal staff Source Type: news

FDA works with technology industry to promote digital health innovation
Scott Gottlieb, FDA commissioner; Jeff Shuren, Center for Devices and Radiological Health director Owing to digital advances, we’re experiencing a reimagination of health care delivery. Consumers are now empowered to take more control of their own health information to make better-informed decisions about their medical care and healthy living. These advances enable better health outcomes for patients. This opportunity is supported by a new technological paradigm of digital health tools, like apps, that enable consumers to have more active engagement and access to real-time information about their health and activitie...
Source: Mass Device - September 13, 2018 Category: Medical Devices Authors: Danielle Kirsh Tags: Blog FDA Voice Source Type: news

Apple Gains FDA Clearance for ECG App for Apple Watch Series 4
Apple Watch Series 4 will feature two new medical apps marketed with FDA’s blessing, thanks to De Novo classifications. The new watch will offer an ECG app, a software-only mobile medical application that can classify whether there are signs of atrial fibrillation (AFib), and another software-only mobile medical app analyzing pulse rates for irregular rhythms. (Neither is intended to replace "traditional methods of diagnosis or treatment," FDA stated in the notices.) These features are scheduled to be available in the United States later this year, ...
Source: MDDI - September 13, 2018 Category: Medical Devices Authors: Daphne Allen Tags: Digital Health Source Type: news

AHA: Apple's Smartwatch Has a Heart Monitor Now
THURSDAY, Sept. 13, 2018 (American Heart Association) -- There will soon be another way to monitor your heart -- from your wrist. The Apple Watch 4 that was unveiled Wednesday will include electrocardiogram testing. Often referred to as an EKG or... (Source: Drugs.com - Daily MedNews)
Source: Drugs.com - Daily MedNews - September 13, 2018 Category: General Medicine Source Type: news

Photos: Apple unveils new Watch with FDA approval and biggest, most expensive iPhone yet
Apple Inc. executives took to the stage at the company's Cupertino headquarters on Wednesday to unveil a lineup of bigger, pricier iPhones and a revamped Apple Watch with new health and medical features and a first-of-its-kind approval from federal drug regulators. The company unveiled a new Apple Watch with an electrical heart rate sensor and new software to detect irregular heart rhythms. The device is the first "over the counter" electrocardiography (ECG) device that has received U.S. Food… (Source: bizjournals.com Health Care:Pharmaceuticals headlines)
Source: bizjournals.com Health Care:Pharmaceuticals headlines - September 13, 2018 Category: Pharmaceuticals Authors: SVBJ staff Source Type: news